Trial Profile
A Long-Term Clinical Study of SFPP in Patients with Osteoarthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Esflurbiprofen (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors Taisho Pharmaceutical
- 26 May 2016 Results published in the Clinical Drug Investigation
- 20 Jan 2016 New trial record